Navidea Biopharmaceuticals Inc (NAVB)

[CarefulTrade]

CHMP today Lots of short activity pre-market.

The CHMP agenda has Lymphoseek in both section 1 and section 2 meaning that the SAG-O material will be reviewed and that an opinion an approval could be given. If approval is recommended then EMA (by their own statistics) is likely (P > 95%) to act within two months. At least one month earlier than I had thought. EU sales are still likely to get roling 2015 just a little earlier if approved.